Cancer prevention and treatment in India

Issues affecting Indian breast cancer treatment

PARP inhibitors

The role of genetic mutations in lung cancer

Environmental tobacco smoke in relation to bladder cancer risk

Attributable risks for hepatocellular carcinoma in the USA

BMI, plasma C-peptide and smoking levels predict prostate cancer outcome

Metabolic pathway genes and bladder cancer risk

Weight gain is associated with an increased risk of prostate cancer recurrence in the PSA era

Preventative oncology in Germany

Highlights in store at the 7th European Breast Cancer Conference, 24 - 27 March

The future of cancer policy in the UK